908 Devices (MASS) Stock Price
908 Devices Price
Revenue has compounded at 15.2% per year over the past 7 years to 56.20 M USD. 908 Devices's net margin stands at -65.2%, down from -53.8% several years earlier. Analysts set a median price target of 12.00 USD, implying 12.5% above the current price. Of 12 analysts, 11 rate the stock a buy — an overall Buy consensus.
908 Devices stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
908 Devices business model & stock analysis
Frequently asked questions about 908 Devices
The business model of 908 Devices Inc. focuses on developing and providing innovative analytical devices for chemical and biomolecular analysis. The company specializes in creating handheld and desktop mass spectrometry instruments that enable real-time, on-site analysis. These devices are designed to deliver accurate and reliable results in various applications such as safety and security, life sciences, and research. 908 Devices Inc. aims to empower scientists, researchers, and field workers with efficient and flexible tools for qualitative and quantitative analysis, ensuring faster decision-making processes and improved productivity in their respective industries.
908 Devices Inc. is primarily active in the industries of chemical, life sciences, and safety and security.
The main competitors of 908 Devices Inc. in the market include companies such as Agilent Technologies, PerkinElmer, Thermo Fisher Scientific, Waters Corporation, and Bruker Corporation.
908 Devices Inc. is a leading provider of mass spectrometry solutions. Founded in 2012, the company is based in Boston, Massachusetts. With a strong focus on delivering innovative chemical analysis tools, 908 Devices Inc. has developed cutting-edge technologies that enable reliable and fast chemical analysis both in the lab and in the field. Their portable and handheld devices are widely used for applications including safety and security, life sciences, and first responder efforts. With a commitment to pushing the boundaries of analytical capabilities, 908 Devices Inc. continues to revolutionize the field of mass spectrometry through their advanced and user-friendly solutions.
Some significant milestones achieved by 908 Devices Inc. include the successful development and launch of their flagship product, the M908™ handheld mass spectrometer, which revolutionized chemical analysis in the field; their collaboration with federal and local law enforcement agencies to enhance security and threat detection capabilities; and their expansion into new markets and industries, such as forensics, environmental analysis, and safety and security. The company has also received numerous awards and recognition for their innovative technologies and contributions to the scientific community.
908 Devices Inc. is primarily present in the United States and Canada.
908 Devices Inc. represents a commitment to advancing science and public safety through innovative technologies. The company focuses on developing and commercializing purpose-built devices for chemical analysis, enabling first responders and scientists to make informed decisions quickly and accurately. 908 Devices Inc. values collaboration, driven by a passion for addressing real-world challenges in research, life sciences, and safety and security industries. With a customer-centric approach, the company strives to deliver solutions that empower users with actionable insights. The corporate philosophy of 908 Devices Inc. revolves around pushing the boundaries of science and using technology to enhance the well-being of society.
Analysts currently set an average price target of 12.00 USD for the 908 Devices stock (median: 12.00 USD), implying +12.5 % versus the latest price. The consensus is based on 12 analyst ratings.
12 analysts currently rate the 908 Devices stock: 11 recommend buying, 1 holding and 0 selling. For 2026, analysts expect 908 Devices to generate revenue of 69.17 M USD and earnings per share of -0.85 USD.
Converted at the current exchange rate, the 908 Devices share trades at 9.50 EUR (10.67 USD).
The 908 Devices share (MASS) is listed on 1 stock exchanges, including: NASDAQ (MASS).
The company 908 Devices Inc. specializes in manufacturing portable devices for chemical analysis. They offer a range of products, including the Momentum product line which includes portable mass spectrometers and gas chromatographs. They also provide the ZipChip system for protein analysis. 908 Devices focuses on specific industries such as life sciences, chemistry, security and defense, and energy. Their devices offer improved mobility, flexibility, and efficiency compared to traditional analysis methods. Their customers include pharmaceutical and biotech companies, research institutions, and regulatory authorities. 908 Devices' unique business model is based on portable devices and advanced technologies tailored to specific industry needs.
The expected revenue of 908 Devices is 69.17 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of 908 Devices is -33.20 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of 908 Devices is currently -12.51. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the 908 Devices stock.
The price-to-sales ratio (P/S) of 908 Devices is currently 6.00. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the 908 Devices stock.
The Eulerpool Quality Score for 908 Devices is 4/10.
The ISIN of 908 Devices is US65443P1021. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of 908 Devices is A2QK1S. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of 908 Devices is MASS. The ticker symbol is used to trade 908 Devices shares on the stock exchange.
908 Devices stock
908 Devices Peer Group
908 Devices Ticker
908 Devices FIGI
All fundamentals and in-depth analysis of 908 Devices
Our stock analysis for 908 Devices stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of 908 Devices. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.